Free Trial

Dynamic Technology Lab Private Ltd Has $800,000 Stock Holdings in Aspen Aerogels, Inc. $ASPN

Aspen Aerogels logo with Construction background

Key Points

  • Dynamic Technology Lab Private Ltd increased its stake in Aspen Aerogels by 91.2% during the first quarter, owning 0.15% of the company worth $800,000.
  • Aspen Aerogels recently reported a quarterly revenue of $78.02 million, exceeding analyst estimates, while posting a loss of ($0.04) EPS.
  • Institutional investors currently hold 97.64% of Aspen Aerogels' stock, indicating strong institutional interest in the company.
  • Five stocks we like better than Aspen Aerogels.

Dynamic Technology Lab Private Ltd boosted its position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 91.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 125,156 shares of the construction company's stock after acquiring an additional 59,685 shares during the period. Dynamic Technology Lab Private Ltd owned 0.15% of Aspen Aerogels worth $800,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in ASPN. Banque Cantonale Vaudoise bought a new position in Aspen Aerogels in the first quarter valued at about $45,000. Exchange Traded Concepts LLC boosted its holdings in Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after acquiring an additional 6,109 shares during the last quarter. CWM LLC boosted its holdings in Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after acquiring an additional 7,953 shares during the last quarter. Teacher Retirement System of Texas bought a new position in Aspen Aerogels in the first quarter valued at about $65,000. Finally, FORA Capital LLC bought a new position in Aspen Aerogels in the first quarter valued at about $79,000. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Barclays cut Aspen Aerogels from an "equal weight" rating to an "underweight" rating and raised their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Check Out Our Latest Research Report on Aspen Aerogels

Aspen Aerogels Trading Down 2.9%

ASPN traded down $0.20 during midday trading on Friday, reaching $6.60. 1,341,668 shares of the company were exchanged, compared to its average volume of 1,402,155. The stock has a market capitalization of $543.58 million, a P/E ratio of -1.73 and a beta of 2.65. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. The stock's 50-day simple moving average is $7.12 and its 200 day simple moving average is $6.47. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.08. The company had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.Aspen Aerogels's revenue was down 33.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares of the company's stock, valued at $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 3.40% of the stock is currently owned by corporate insiders.

About Aspen Aerogels

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Stories

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.